Joseph Michael Fitzgerald - Feb 15, 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Signature
/s/ Vance R. Brown, Attorney-in-fact
Stock symbol
BSX
Transactions as of
Feb 15, 2022
Transactions value $
-$100,255
Form type
4
Date filed
2/17/2022, 07:12 PM
Previous filing
Jan 3, 2022
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Gift $0 -2.78K -1.32% $0.00 208K Feb 7, 2022 Direct F1
transaction BSX Common Stock Options Exercise $0 +4.61K +2.22% $0.00 212K Feb 15, 2022 Direct F2
transaction BSX Common Stock Tax liability -$100K -2.28K -1.07% $44.01 210K Feb 15, 2022 Direct
transaction BSX Common Stock Gift $0 +1.39K +23.02% $0.00 7.43K Feb 7, 2022 By Children F1, F3
holding BSX Common Stock 68.2K Feb 15, 2022 By 401(k) F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Options Exercise $0 -4.61K -49.99% $0.00 4.62K Feb 15, 2022 Common Stock 4.61K Direct F2, F5
transaction BSX Restricted Stock Units Award $0 +15.8K $0.00 15.8K Feb 16, 2022 Common Stock 15.8K Direct F6, F7
transaction BSX Stock Option (Right to Buy) Award $0 +45.3K $0.00 45.3K Feb 16, 2022 Common Stock 45.3K $44.19 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a gift of securities by the reporting person to his children, two of whom share the reporting person's household.
F2 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3 The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
F4 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F5 Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F6 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F8 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

Remarks:

fitzgeraldpoa.txt